216 related articles for article (PubMed ID: 33674865)
21. Medical device; exemption from premarket notification; class II devices; barium enema retention catheters and tips with or without a bag. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Dec; 65(237):76930-2. PubMed ID: 11503724
[TBL] [Abstract][Full Text] [Related]
22. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
[TBL] [Abstract][Full Text] [Related]
23. The Role of the FDA in Ensuring the Safety and Efficacy of Artificial Intelligence Software and Devices.
Allen B
J Am Coll Radiol; 2019 Feb; 16(2):208-210. PubMed ID: 30389329
[No Abstract] [Full Text] [Related]
24. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
[TBL] [Abstract][Full Text] [Related]
25. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
[TBL] [Abstract][Full Text] [Related]
26. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
Muehlematter UJ; Daniore P; Vokinger KN
Lancet Digit Health; 2021 Mar; 3(3):e195-e203. PubMed ID: 33478929
[TBL] [Abstract][Full Text] [Related]
27. Medical Devices; Exemptions From Premarket Notification: Class II Devices. Final order.
Food and Drug Administration, HHS
Fed Regist; 2018 Jun; 83(108):25910-5. PubMed ID: 30019871
[TBL] [Abstract][Full Text] [Related]
28. General and plastic surgery devices; effective date of requirement for premarket approval of the silicone inflatable breast prosthesis. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist; 1999 Aug; 64(160):45155-61. PubMed ID: 10558602
[TBL] [Abstract][Full Text] [Related]
29. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
30. An FDA Guide on Indications for Use and Device Reporting of Artificial Intelligence-Enabled Devices: Significance for Pediatric Use.
Nelson BJ; Zeng R; Sammer MBK; Frush DP; Delfino JG
J Am Coll Radiol; 2023 Aug; 20(8):738-741. PubMed ID: 37400046
[TBL] [Abstract][Full Text] [Related]
31. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
32. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals.
Wu E; Wu K; Daneshjou R; Ouyang D; Ho DE; Zou J
Nat Med; 2021 Apr; 27(4):582-584. PubMed ID: 33820998
[No Abstract] [Full Text] [Related]
33. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
34. More than algorithms: an analysis of safety events involving ML-enabled medical devices reported to the FDA.
Lyell D; Wang Y; Coiera E; Magrabi F
J Am Med Inform Assoc; 2023 Jun; 30(7):1227-1236. PubMed ID: 37071804
[TBL] [Abstract][Full Text] [Related]
35. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
Golish SR; Reed ML
Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
[TBL] [Abstract][Full Text] [Related]
36. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
Woo JH; Kim EC; Kim SM
Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
[TBL] [Abstract][Full Text] [Related]
37. The regulatory environment for artificial intelligence-enabled devices in the United States.
Liang NL; Chung TK; Vorp DA
Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617
[TBL] [Abstract][Full Text] [Related]
38. Medical devices; exemptions from premarket notification; surgical lamps--FDA. Notice.
Fed Regist; 1998 Dec; 63(233):67075-6. PubMed ID: 10338882
[TBL] [Abstract][Full Text] [Related]
39. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
40. FDA recognition of consensus standards in the premarket notification program.
Marlowe DE; Phillips PJ
Biomed Instrum Technol; 1998; 32(3):301-4. PubMed ID: 9619259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
